Jansman, Frank G.A.; Postma, Maarten J.; Brouwers, … - In: PharmacoEconomics 25 (2007) 7, pp. 537-562
survival, cost-effectiveness analysis is considered not to be applicable and cost-minimisation analysis may be sufficient. At … available, except for recent cost-effectiveness considerations by the UK National Institute for Health and Clinical Excellence … for colorectal cancer, examination of cost-effectiveness studies should be conducted on a routine basis along with …